Literature DB >> 22763482

Hypertension and life expectancy among Japanese: NIPPON DATA80.

Tanvir Chowdhury Turin1, Yoshitaka Murakami, Katsuyuki Miura, Nahid Rumana, Yoshikuni Kita, Takehito Hayakawa, Tomonori Okamura, Akira Okayama, Hirotsugu Ueshima.   

Abstract

Life expectancy (LE) is a measure that describes the health status of a population. The few published studies that have examined the impact of hypertension on LE were predominantly performed in Western populations. The effect of hypertension on LE has not been reported in an Asian population. Thus, we examined the impact of hypertension on LE in the Japanese population, which has the highest LE worldwide. The abridged life table method was applied to calculate the LEs of both normotensive and hypertensive men and women aged 40-85 years. Hypertensive participants were categorized as having either stage 1 or stage 2 hypertension. Age-specific mortality rates across different groups were estimated using the person-year method based on the follow-up data from a representative Japanese population in a national survey (NIPPON DATA80). The proportion of hypertensive patients in the baseline survey was 50.5% for men and 41.4% for women. The LE of 40-year-old men and women was 41.7 years and 48.7 years, respectively, in normotensive participants and 39.5 and 45.8 years, respectively, in hypertensive participants. The LE difference between normotensive and hypertensive participants was 2.2 years for men and 2.9 years for women. LE decreased with increasing stages of hypertension. Similar patterns of LE, with respect to blood pressure (BP) status, were observed in all index ages and for both genders. At the population level, hypertension leads to decreased LE and affects both genders similarly. Our findings highlight the importance of preventing high BP and the consequences of hypertension in Japanese population.

Entities:  

Mesh:

Year:  2012        PMID: 22763482     DOI: 10.1038/hr.2012.86

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  9 in total

1.  Burden of CKD and Cardiovascular Disease on Life Expectancy and Health Service Utilization: a Cohort Study of Hong Kong Chinese Hypertensive Patients.

Authors:  Eric Yuk Fai Wan; Esther Yee Tak Yu; Weng Yee Chin; Daniel Yee Tak Fong; Edmond Pui Hang Choi; Eric Ho Man Tang; Cindy Lo Kuen Lam
Journal:  J Am Soc Nephrol       Date:  2019-09-06       Impact factor: 10.121

2.  Relationship between outpatient visit frequency and hypertension control: a 9-year occupational cohort study.

Authors:  Azusa Shima; Yukako Tatsumi; Tatsuro Ishizaki; Kayo Godai; Yuichiro Kawatsu; Tomonori Okamura; Tomofumi Nishikawa; Akiko Morimoto; Ayumi Morino; Naomi Miyamatsu
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

Review 3.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

4.  Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide.

Authors:  Yi-Ting Lin; Yen-Chun Huang; Chih-Kuan Liu; Tian-Shyug Lee; Mingchih Chen; Yu-Ning Chien
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

5.  Social media in communicating health information: an analysis of Facebook groups related to hypertension.

Authors:  Mohammad Al Mamun; Hamza M Ibrahim; Tanvir Chowdhury Turin
Journal:  Prev Chronic Dis       Date:  2015-01-29       Impact factor: 2.830

6.  Hypertension: empirical evidence and implications in 2014.

Authors:  Spyros Makridakis; James J DiNicolantonio
Journal:  Open Heart       Date:  2014-07-10

7.  Kidney function, albuminuria and life expectancy.

Authors:  Tanvir Chowdhury Turin; Sofia B Ahmed; Marcello Tonelli; Braden Manns; Pietro Ravani; Matthew James; Robert R Quinn; Min Jun; Ron Gansevoort; Brenda Hemmelgarn
Journal:  Can J Kidney Health Dis       Date:  2014-12-19

8.  Multi-state analysis of hypertension and mortality: application of semi-Markov model in a longitudinal cohort study.

Authors:  Azra Ramezankhani; Michael J Blaha; Mohammad Hassan Mirbolouk; Fereidoun Azizi; Farzad Hadaegh
Journal:  BMC Cardiovasc Disord       Date:  2020-07-06       Impact factor: 2.298

9.  Cluster-randomized controlled trial for the early promotion of clinic visits for untreated hypertension.

Authors:  Azusa Shima; Hisatomi Arima; Katsuyuki Miura; Yukako Tatsumi; Takayoshi Ohkubo; Yuichiro Kawatsu; Ayumi Morino; Takashi Kimura; Kayo Godai; Saori Azuma; Naomi Miyamatsu
Journal:  Hypertens Res       Date:  2020-10-14       Impact factor: 3.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.